Bixiye
QP91-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1821 - 1830 ee natiijooyinka 3167
Bixiye
QP92-22 MHCP Pharmacy Benefit Exclusion for Cimerli™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
QP94-22 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
QP93-22 MHCP Pharmacy Benefit Exclusion for Pedmark®, Rolvedon™, Skysona®, Spevigo®, and Xenpozyme™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
QP90-22 Provider Press: Q4 2022
Taariikhda uu dhaqangalayo Barnaamijka: Nov 09, 2022
Bixiye
P67-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Laboratory Management Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2022
Bixiye
2022 November Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2022
Bixiye
P73-22 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2022
Bixiye
P72-22 Nurse Practitioner and Physician Assistant Services Reimbursement Policy for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2022
Bixiye
P70-22 Medicare Advantage Behavioral Health Claims Update
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2022